{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:27:33Z","timestamp":1773030453427,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MSD"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Bone turnover balance favors bone formation, especially mineralization, during the first 3 years of treatment with TNF-\u03b1 inhibitors (TNFi). Our aim was to evaluate the course of serum bone turnover markers (BTM) and to investigate if facilitation of mineralization reflected by BTM BALP continues to increase during 6 years of TNFi treatment in patients with ankylosing spondylitis (AS) in daily clinical practice.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Included were outpatients from the University Medical Center Groningen (UMCG) participating in the Groningen Leeuwarden Axial SpA (GLAS) cohort who were treated with TNFi for at least 6 years. Serum markers of collagen resorption, bone regulation, collagen formation and facilitator of bone mineralization (sCTX, OC, PINP and BALP, respectively) were measured at baseline, 3 and 6 months, 1, 2, 4 and 6 years. Z-scores were calculated to correct for age and gender.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>53 AS patients were eligible for analyses (66% male, mean age 39\u00b111 years). Disease activity showed rapid and sustained improvement after start of TNFi. Evaluating BTM, sCTX did not significantly change during 6 years of treatment. OC was only significantly increased at 3 months compared to baseline, with median change in Z-score of +0.5. PINP significantly increased at 3 and 6 months and 2 years of treatment, with maximum median change in Z-score of +0.3. Interestingly, BALP was significantly increased at all time points up to and including 2 years of TNFi treatment, with maximum change in median Z-score of +1.2, and decreased thereafter.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In AS patients receiving long-term TNFi, bone turnover balance favored collagen formation and facilitation of mineralization during the first 2 years of treatment. Thereafter, at 4 and 6 years of follow-up, BTM Z-scores returned to pre-treatment levels.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0283579","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T17:36:31Z","timestamp":1679679391000},"page":"e0283579","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-\u03b1 inhibition in patients with ankylosing spondylitis"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-4341","authenticated-orcid":true,"given":"Mark","family":"Siderius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8850-8578","authenticated-orcid":true,"given":"Anneke","family":"Spoorenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans G. M.","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline","family":"van der Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-7640","authenticated-orcid":true,"given":"Suzanne","family":"Arends","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"pone.0283579.ref001","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/BOR.0000000000000053","article-title":"Clinical studies on bone-related outcome and the effect of TNF-\u03b1 blocking therapy in ankylosing spondylitis.","volume":"26","author":"S Arends","year":"2014","journal-title":"Curr Opin Rheumatol [Internet]."},{"key":"pone.0283579.ref002","article-title":"Bone Involvement in Patients with Spondyloarthropathies","author":"W Lems","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"pone.0283579.ref003","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"D van der Heijde","year":"2017","journal-title":"Ann Rheum Dis [Internet]."},{"key":"pone.0283579.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11280","article-title":"Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.","volume":"11","author":"C McLeod","year":"2007","journal-title":"Health Technol Assess"},{"key":"pone.0283579.ref005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.2007.084426","article-title":"Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis","volume":"68","author":"S Visvanathan","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"pone.0283579.ref006","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/ar3823","article-title":"The effect of three years of TNF-alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study.","volume":"14","author":"S Arends","year":"2012","journal-title":"Arthritis Res Ther [Internet]."},{"issue":"Suppl 2","key":"pone.0283579.ref007","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.","volume":"68","author":"J Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"pone.0283579.ref008","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.62.9.817","article-title":"International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis","volume":"62","author":"J Braun","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"pone.0283579.ref009","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.20446","article-title":"What is the most appropriate radiologic scoring method for ankylosing spondylitis?","volume":"50","author":"AJB Wanders","year":"2004","journal-title":"Arthritis Rheum [Internet]."},{"key":"pone.0283579.ref010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/annrheumdis-2013-204055","article-title":"Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study","volume":"74","author":"S Ramiro","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"pone.0283579.ref011","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/acr.23097","article-title":"Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.","volume":"69","author":"F Maas","year":"2017","journal-title":"Arthritis Care Res (Hoboken) [Internet]."},{"key":"pone.0283579.ref012","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1023\/B:EJEP.0000036572.00663.f2","article-title":"Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis","volume":"19","author":"JWR Twisk","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"pone.0283579.ref013","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone Quality\u2014The Material and Structural Basis of Bone Strength and Fragility","volume":"354","author":"E Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"pone.0283579.ref014","doi-asserted-by":"crossref","first-page":"e0177231","DOI":"10.1371\/journal.pone.0177231","article-title":"Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-\u03b1 inhibitors.","volume":"12","author":"F Maas","year":"2017","journal-title":"PLoS One"},{"key":"pone.0283579.ref015","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-010-1338-7","article-title":"The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.","volume":"22","author":"S Arends","year":"2011","journal-title":"Osteoporos Int [Internet]."},{"key":"pone.0283579.ref016","first-page":"1","article-title":"Normal bone physiology, remodelling and its hormonal regulation.","volume":"33","author":"JS Walsh","year":"2015","journal-title":"Surg"},{"key":"pone.0283579.ref017","first-page":"1","article-title":"Classical and Paradoxical Effects of TNF-\u03b1 on Bone Homeostasis.","volume":"5","author":"B Osta","year":"2014","journal-title":"Front Immunol [Internet]."},{"key":"pone.0283579.ref018","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","article-title":"Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts","volume":"275","author":"Y Azuma","year":"2000","journal-title":"J Biol Chem [Internet]."},{"key":"pone.0283579.ref019","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/path.1190","article-title":"Proinflammatory cytokine (TNFalpha\/IL-1alpha) induction of human osteoclast formation.","volume":"198","author":"O Kudo","year":"2002","journal-title":"J Pathol"},{"key":"pone.0283579.ref020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-5122(03)00282-2","article-title":"Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.","volume":"47","author":"EF Papakitsou","year":"2004","journal-title":"Maturitas [Internet]."},{"key":"pone.0283579.ref021","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/endo.141.11.7739","article-title":"Inhibition of osteoblast differentiation by tumor necrosis factor-alpha","volume":"141","author":"L Gilbert","year":"2000","journal-title":"Endocrinology [Internet]."},{"key":"pone.0283579.ref022","first-page":"1753","article-title":"Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept","volume":"34","author":"J Woo","year":"2007","journal-title":"J Rheumatol"},{"key":"pone.0283579.ref023","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10067-019-04771-3","article-title":"Effects of 1-year anti-TNF-\u03b1 therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"K Guly\u00e1s","year":"2020","journal-title":"Clin Rheumatol"},{"key":"pone.0283579.ref024","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1152\/jappl.2001.90.2.565","article-title":"Weight-bearing exercise and markers of bone turnover in female athletes","volume":"90","author":"DL Creighton","year":"2001","journal-title":"J Appl Physiol [Internet]."},{"key":"pone.0283579.ref025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00296-014-3141-9","article-title":"Physical activity in spondyloarthritis: a systematic review.","volume":"35","author":"T O\u2019Dwyer","year":"2015","journal-title":"Rheumatol Int."},{"key":"pone.0283579.ref026","doi-asserted-by":"crossref","first-page":"e85309","DOI":"10.1371\/journal.pone.0085309","article-title":"Physical activity assessment in patients with axial spondyloarthritis compared to healthy controls: a technology-based approach.","volume":"9","author":"TW Swinnen","year":"2014","journal-title":"PLoS One"},{"key":"pone.0283579.ref027","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.lfs.2009.01.013","article-title":"TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells","volume":"84","author":"J Ding","year":"2009","journal-title":"Life Sci [Internet]."},{"key":"pone.0283579.ref028","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bone.2010.09.001","article-title":"TNF-\u03b1 stimulates alkaline phosphatase and mineralization through PPAR\u03b3 inhibition in human osteoblasts","volume":"48","author":"P Lencel","year":"2011","journal-title":"Bone"},{"key":"pone.0283579.ref029","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"D Diarra","year":"2007","journal-title":"Nat Med [Internet]."},{"key":"pone.0283579.ref030","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1136\/annrheumdis-2013-204485","article-title":"Evidence in support of the validity of the TNF brake hypothesis","volume":"72","author":"WP Maksymowych","year":"2013","journal-title":"Ann Rheum Dis [Internet]."},{"key":"pone.0283579.ref031","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.actbio.2019.03.020","article-title":"Hypermineralization in the femoral neck of the elderly.","volume":"89","author":"T Tang","year":"2019","journal-title":"Acta Biomater [Internet]."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0283579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T17:37:11Z","timestamp":1679679431000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0283579"}},"subtitle":[],"editor":[{"given":"J. J.","family":"Cray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0283579","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]}}}